Prosecution Insights
Last updated: May 29, 2026

Examiner: GANGLE, BRIAN J

Tech Center 1600 • Art Units: 1645 1647

This examiner grants 76% of resolved cases

Performance Statistics

76.4%
Allow Rate
+16.4% vs TC avg
980
Total Applications
+15.4%
Interview Lift
948
Avg Prosecution Days
Based on 942 resolved cases, 2023–2026

Rejection Statute Breakdown

1.9%
§101 Eligibility
24.6%
§102 Novelty
28.4%
§103 Obviousness
33.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18006385 METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE AND ALLERGIC DISORDERS Non-Final OA THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
18114092 USES OF UROLITHINS Non-Final OA Amazentis SA
18011338 OLFACTORY RECEPTORS FOR USE AS TARGETS FOR ANTIGEN BINDING MOLECULES TO DETECT AND TREAT CANCER Non-Final OA H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
18566497 MINICELLS FROM HIGHLY GENOME REDUCED ESCHERICHIA COLI: CYTOPLASMIC AND SURFACE EXPRESSION OF RECOMBINANT PROTEINS AND INCORPORATION IN THE MINICELLS Non-Final OA University of Virginia Patent Foundation
18562387 RECOMBINANT EXPRESSION OF KLEBSIELLA PNEUMONIAE O-ANTIGENS IN ESCHERICHIA COLI Non-Final OA Pfizer Inc.
18702767 LIPOPOLYSACCHARIDE (LPS) DEFICIENT ACINETOBACTER BAUMANNII MULTIVALENT VACCINE Non-Final OA INSTITUTO DE SALUD CARLOS III
18694632 MEDICAMENT FOR KILLING TUMOR CELLS Non-Final OA NIPPON MEDICAL SCHOOL FOUNDATION
18604772 BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS ATM-209 INHIBITING HELICOBACTER PYLORI AND APPLICATION THEREOF Non-Final OA SHENZHEN PORSHEALTH BIOENGINEERING CO., LTD.
18291001 Method for Purification of Botulinum Toxin Complex with Improved Purification Yield Non-Final OA INIBIO CO., LTD.
18576556 METHOD FOR PURIFICATION OF CLOSTRIDIUM BOTULINUM NEUROTOXIN PROTEIN DEPRIVED OF NON-TOXIN PROTEIN Non-Final OA PHARMA RESEARCH BIO CO., LTD.
18275463 VACCINE AND METHODS FOR PREVENTING FILARIASIS AND DIROFILARIASIS Non-Final OA PAI LIFE SCIENCES INC.
18259633 IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SWINE DYSENTERY Non-Final OA HIPRA SCIENTIFIC, S.L.U.
18038032 BACILLUS SUBTILIS STRAIN WITH STRONG INHIBITION OF ENTEROPATHOGENIC AND FOODBORNE PATHOGENIC BACTERIA Non-Final OA lowa State University Research Foundation, Inc.
18302656 METHODS FOR TREATING AUTISM SPECTRUM DISORDER Non-Final OA Genevive, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month